Skip to content
Dr. Ismail D Badjie, PharmD
Menu
Dr. Ismail D Badjie, PharmD

Keynote Speaker · Healthcare Operator

Healthcare operator.
Frontier-market builder.
Keynote speaker.

Building healthcare infrastructure that serves 200,000+ patients across The Gambia — and bringing those frontier-market lessons to stages worldwide.

Selected stages.

  • Stanford Seed Transformation Program
  • TAFCON
  • African Commission on Human and Peoples’ Rights
  • African Youth Leadership Hub
  • Gambian National Health Platforms
200,000+
patients served across five regions of The Gambia.
$2M on $740K
revenue generated through COVID and a 2024 regulatory shutdown.
Medicines Act
2025
advocated and passed into Gambian law.

Signature talks

Built for stages that take ideas seriously.

Five keynotes drawn from a decade of frontier-market operating experience — calibrated for business schools, philanthropic funders, founder communities, public-health summits, and diaspora audiences.

All five talks
  • Talk 01

    Built Through Fire

    Lessons from a regulatory shutdown, a pandemic, and a continent worth fighting for.

    Read more
  • Talk 02

    The Silence That's Killing Men

    Building community health through the conversations no one wants to have.

    Read more
  • Talk 03

    Community Health, Rebuilt

    An operator's playbook for non-communicable diseases in frontier markets.

    Read more
  • Talk 04

    Truth and Optimism

    What Africa's young builders actually need to hear.

    Read more
  • Talk 05 · In development

    Coming Home

    The diaspora's case for building Africa now.

    Read more

About

Eleven years
building healthcare
in The Gambia
from inside it.

200K+
Patients served
5
Regions of The Gambia
$2M / $740K
Revenue / capital
Medicines
Act 2025
Advocated & passed

Dr. Badjie trained at Tennessee State (B.Sc. Chemistry, magna cum laude) and Purdue University College of Pharmacy (PharmD), then managed Walgreens HIV Centers of Excellence in Charlotte and Raleigh before founding InnovaRx Global Health in 2015. He returned to The Gambia in 2019 to open the country operation, which today reaches more than 200,000 patients across all five regions.

Through COVID, a 2024 regulatory shutdown that confiscated FDA-approved medications, and years of capital constraint, he kept the company building — generating $2M+ in revenue on $740K raised. As founding President of GARPA, he led the advocacy that produced the Medicines and Related Products Amendment Act 2025.

He is a Stanford Seed Transformation Program 2024 alumnus, a Purdue Eaton Entrepreneur of the Year, and currently serves as Program Manager for a $1.17M Global Fund GC7 HIV Prevention sub-recipient grant under ActionAid International The Gambia.

Read full bio

Ventures

Three companies. One thesis.

Dr. Badjie operates a vertically integrated group focused on the unfinished work of building healthcare infrastructure in West Africa — from delivery to wholesale to capital structure.

All three ventures
  • Operating company

    InnovaRx Global Health

    West Africa’s first vertically integrated pharmaceutical and HIV service-delivery platform. 200,000+ patients across all five regions of The Gambia.

  • Pharmaceutical wholesale

    Kartan Pharma

    Licensed pharmaceutical import, warehousing, and wholesale for West Africa. Active Series A with development finance institutions and impact investors.

  • Parent entity

    Kartan Holdings

    Delaware-domiciled parent for Kartan Pharma, Kartan Health Club, and Kartan Water; vehicle for the group’s capital structure and cross-border partnerships.

    Learn more
“Healthcare in Africa doesn't need more consultants — it needs builders. I bring both perspectives to every engagement.”

Dr. Ismail D Badjie, PharmD

Founder & CEO, Innovarx Global Health

Speaking inquiries

Bring this conversation to your stage.